BEAM THERAPEUTICS INC shareholders Q4 2022

BEAM THERAPEUTICS INC's ticker is BEAM and the CUSIP is 07373V105. A total of 211 filers reported holding BEAM THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 2.00 and the average weighting 0.3%.

BEAM THERAPEUTICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
Hemenway Trust Co LLC 5,680$222,1450.02%
Tekla Capital Management LLC 15,817$618,6030.02%
Mirae Asset Global Investments Co., Ltd. 216,485$8,466,7280.02%
PROFUND ADVISORS LLC 8,118$317,4950.02%
Sumitomo Mitsui Trust Holdings, Inc. 673,690$26,348,0160.02%
Candriam S.C.A. 79,665$3,115,5520.02%
FMR LLC 4,965,989$194,219,8320.02%
Baillie Gifford 454,828$17,788,3240.02%
CAPITAL FUND MANAGEMENT S.A. 67,942$2,657,2110.02%
High Net Worth Advisory Group LLC 1,000$39,1100.02%
China Universal Asset Management Co., Ltd. 952$370.02%
AllSquare Wealth Management LLC 560$21,9020.02%
Quantbot Technologies LP 5,193$203,0980.02%
Walleye Capital LLC 20,400$797,8440.02%
MUTUAL OF AMERICA CAPITAL MANAGEMENT LLC 27,753$1,085,4200.01%
SCHRODER INVESTMENT MANAGEMENT GROUP 213,787$8,361,2100.01%
Vident Investment Advisory, LLC 8,520$333,2180.01%
Caption Management, LLC 20,000$782,2000.01%
Spire Wealth Management 5,465$2140.01%
Caption Management, LLC 20,000$782,2000.01%
External links

This page lists BEAM THERAPEUTICS INC's shareholders in Q4 2022. To view BEAM THERAPEUTICS INC's shareholder history, click here.